Last updated on June 2019

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC


Brief description of study

The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease

Clinical Study Identifier: NCT03215706

Find a site near you

Start Over

Lancaster General Hospital

Lancaster, PA United States
  Connect »

Local Institution

Montreal, QC Canada
  Connect »

Local Institution

Cluj-Napoca, Romania
  Connect »

Local Institution

Moscow, Russian Federation
  Connect »

Local Institution

St.petersburg, Russian Federation
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Maidstone, United Kingdom
  Connect »

Local Institution

Guildford, United Kingdom
  Connect »

Local Institution

Tauton, United Kingdom
  Connect »

Baptist MD Anderson Cancer Center

Jacksonville, FL United States
  Connect »

Local Institution

Atlanta, GA United States
  Connect »

Local Institution

LaGrange, GA United States
  Connect »

Baptist Health Lexington

Lexington, KY United States
  Connect »

Broome Oncology

Johnson City, NY United States
  Connect »

Local Institution

Milwaukee, WI United States
  Connect »

Local Institution

Bedford Park, Australia
  Connect »

Local Institution

Elizabeth Vale, Australia
  Connect »

Local Institution

Box Hill, Australia
  Connect »

Local Institution

Heidelberg, Australia
  Connect »

Local Institution

Porto Alegre, Brazil
  Connect »

Local Institution

Sao Jose De Rio Preto, Brazil
  Connect »

Local Institution

Rio De Janeiro, Brazil
  Connect »

Local Institution

Amiens Cedex 1, France
  Connect »

Local Institution

Lille Cedex, France
  Connect »

Local Institution

Lyon Cedex 08, France
  Connect »

Local Institution

Montpellier Cedex, France
  Connect »

Cancer Center Of Kansas

Wichita, KS United States
  Connect »

The Ohio State University

Columbus, OH United States
  Connect »

Local Institution

Fukushima-shi, Japan
  Connect »

Local Institution

Kanazawa-shi, Japan
  Connect »

Local Institution

Yokohama-Shi, Japan
  Connect »

Local Institution

Osaka-sayama-shi, Japan
  Connect »

Local Institution

Kitaadachi-gun, Japan
  Connect »

Local Institution

Guadalajara, Mexico
  Connect »

Local Institution

Maebashi-shi, Japan
  Connect »

Local Institution

Saint-Brieuc, France
  Connect »

Henry Ford Health System

Detroit, MI United States
  Connect »

Sanatorio Parque

Rosario, Argentina
  Connect »

Oncotech

La Paz, Mexico
  Connect »

Memorial Health Systems

Colorado Springs, CO United States
  Connect »

Faicic S. de Rl. de Cv

Veracruz, Veracruz, Mexico
  Connect »

Southwest Regional Cancer Clinic

Saint George, UT United States
  Connect »

Local Institution

Hiroshima-shi, Japan
  Connect »

Local Institution

Yokohama-shi, Japan
  Connect »

Local Institution

Habikino-shi, Japan
  Connect »

West Penn Hospital

Pittsburgh, PA United States
  Connect »

UPMC Hillman Cancer Center

Pittsburgh, PA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.